Geron Corporation to Present at BIO CEO Conference.MENLO PARK, Calif. -- Geron Corporation (Nasdaq:GERN v. t. 1. To grin or yawn. ) will be presenting a company overview on Wednesday, February 23, 2005, at the Biotechnology Industry Organization's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Investor Conference at 11:00 a.m., Eastern Time. The presentation will highlight the company's current product development efforts in oncology and human embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. therapies. The review of Geron's portfolio of telomerase-based anti-cancer therapies will include an update on GRN GRN Green GRN Green (Political) Party GRN Global Recycling Network GRN Gulf Restoration Network (New Orleans, LA) GRN Goods Received Note GRN Global Reference Network (GPS) 163L and progress on the ex vivo telomerase vaccine. The presentation will also include updates on the company's latest human embryonic stem cell (hESC) research in spinal cord injury Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. , diabetes and heart disease. Thomas B. Okarma, Ph.D., M.D., Geron's president and chief executive officer, will be giving the presentation. The audio and slide presentation will be available at the following website address: http://www.corporate-ir.net/ireye/confLobby .zhtml?ticker=GERN&item_id=1009128. (Due to its length, this URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.) It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a replay will be available at this address within 24 hours of the presentation and for a period of 30 days. For further information, please contact Geron Corporation at 650-473-7765, or visit Geron's website at www.geron.com or BIO's website at www.bio.org. Geron is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for cancer based on its telomerase technology, and cell-based therapeutics using its human embryonic stem cell technology. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion